© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Repare Therapeutics Inc. (RPTX) shows an Average True Range (ATR) of 0.1 and an Enterprise Value of 31.34M. Its average trading volume over the past 3 months is 771.94K, indicating liquidity. These fundamental metrics provide insight into RPTX's underlying financial health and market activity.
Repare Therapeutics Inc. (RPTX) technical indicators as of December 25, 2025: the SMA 20 is 16.31%, SMA 50 at 27.12%, and SMA 200 at 60.84%. The RSI 14 value is 74, suggesting its current momentum. These technical analysis signals help assess RPTX's price trends and potential future movements.
Repare Therapeutics Inc. (RPTX) stock performance overview as of December 25, 2025: The 52-week high is $2.66 (currently 10.87% below), and the 52-week low is $0.89 (currently 186.52% above). Over the past year, RPTX's performance is 102.38%, compared to the S&P 500's 9.35% change.
According to market data, Repare Therapeutics Inc. (RPTX) stock's recent performance metrics show that over the last month, RPTX is 20.85%, with a Year-to-Date (YTD) performance of 94.66%. Over the past year, the stock has seen a 102.38% change. These figures summarize RPTX's price movements across various periods, reflecting its historical returns.
According to current financial data, RPTX stock's P/E (TTM) ratio is -1.52, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for RPTX, including P/S (438.38), P/B (0.95), and P/FCF (-1.56), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.